DOI: 10.36347/sjmcr.2021.v09i05.033

Pages: 581-586

Gougerot-Sjögren's syndrome (GSS) is a systemic autoimmune disease whose target is the epithelium of the exocrine glands and in particular the salivary glands. As a result, the condition is referred to as autoimmune epithelitis [1]. GSS is manifested by a symptomatic triad of dryness, pain and fatigue and may be complicated by systemic complications in 30-50% of patients [2]. Neurological involvement is found in 10-60% of primary Gougerot-Sjögren's syndromes, with highly polymorphic presentations, which may involve both the peripheral and central nervous systems [3]. Involvement of the central nervous system is very rare, affecting less than 5% of patients, and may result in clinical pictures similar to multiple sclerosis [4]. The aim of our study is to illustrate, through a clinical case, the interest of evoking Primary Gougerot-Sjögren's Syndrome in the face of an attack on the central nervous system, in this case an ischemic stroke. The methodology was the study of the clinical file of a patient consulted in the rheumatology department of the CHU Aristide LeDantec in Dakar, Senegal in 2020.